Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 12.20
-0.30 (-2.40%)
Apr 20, 2026, 1:20 PM CST
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 1.13 billion as of April 20, 2026. Its market cap has decreased by -22.36% in one year.
Market Cap
1.13B
Enterprise Value
1.27B
Revenue
371.86M
Ranking
n/a
PE Ratio
48.87
Stock Price
12.20
Market Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 1.13B, a decrease of -72.54%. That is a compound annual growth rate of -9.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.13B | 12.11% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.40B |
| Abnova (Taiwan) | 1.36B |
| Enimmune | 1.34B |
| Great Novel Therapeutics Biotech & Medicals | 1.33B |
| Holy Stone Healthcare | 1.24B |
| Meribank Biotech | 1.16B |
| GeneReach Biotechnology | 1.13B |
| Level Biotechnology | 1.09B |